Comparison of Drug-Coated Balloon versus Plain Balloon Angioplasty for the Treatment of Arteriovenous Fistula Stenosis: A systematic review and meta-analysis of randomized controlled trials
CardioVascular and Interventional Radiology · 2025
DOI: 10.1007/s00270-025-04279-1 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift CardioVascular and Interventional Radiology, 2025. Verfasst von Zhi-Wei Xu und 4 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical College of Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China. Hauptthemen laut MEDLINE: Angioplasty, Balloon, Arteriovenous Shunt, Surgical, Graft Occlusion, Vascular, Coated Materials, Biocompatible. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Drug-coated balloon (DCB) angioplasty is a promising therapy for arteriovenous fistula (AVF) stenosis in hemodialysis patients. However, comparative evidence on the long-term efficacy of DCB versus plain balloon angioplasty (PBA), the sources of heterogeneity, and its differential effects on various access types remains inconclusive. This meta-analysis synthesizes randomized controlled trial (RCT) data to evaluate clinical outcomes of these approaches. MATERIALS: This meta-analysis of randomized controlled trials (RCTs) evaluated DCB versus PBA for AVF stenosis (PROSPERO CRD420250651907). We systematically searched PubMed, Embase, and Web of Science from inception to February 17, 2025, for RCTs reporting 6-month target lesion primary patency. RESULTS: Twenty-one RCTs (n = 2,537 patients) were included. DCB significantly improved primary patency at 6 months (OR 2.43, 95% CI: 1.81-3.27; P = 0.002) and 12 months (OR 1.88, 95% CI: 1.54-2.30; P = 0.230), but the benefit attenuated at 24 months (OR 1.36, 95% CI: 1.00-1.85; P = 0.794). Complication and mortality rates were comparable between groups at all timepoints. CONCLUSIONS: DCB angioplasty provides superior short-to-medium-term primary patency versus PBA for AVF stenosis, although this benefit diminishes with prolonged follow-up. The two modalities show comparable safety. The higher initial cost of DCB necessitates individualized treatment decisions based on patient life expectancy and lesion characteristics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical College of Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China.
- Department of Peripheral Vascular Disease, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China.
- Department of Peripheral Vascular Disease, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, China. haodoctor2@126.com.
Zitieren
APA
Xu, Z. W., Li, H. B., Yang, X. S., Qin, H. S., & Hao, Q. Z. (2025). Comparison of Drug-Coated Balloon versus Plain Balloon Angioplasty for the Treatment of Arteriovenous Fistula Stenosis: A systematic review and meta-analysis of randomized controlled trials. CardioVascular and Interventional Radiology. https://doi.org/10.1007/s00270-025-04279-1
Vancouver
Xu ZW, Li HB, Yang XS, Qin HS, Hao QZ. Comparison of Drug-Coated Balloon versus Plain Balloon Angioplasty for the Treatment of Arteriovenous Fistula Stenosis: A systematic review and meta-analysis of randomized controlled trials. CardioVascular and Interventional Radiology. 2025. doi:10.1007/s00270-025-04279-1
BibTeX
@article{Xu2025,
author = {Xu, Zhi-Wei and Li, Han-Bo and Yang, Xue-Song and Qin, Hong-Song and Hao, Qing-Zhi},
title = {Comparison of Drug-Coated Balloon versus Plain Balloon Angioplasty for the Treatment of Arteriovenous Fistula Stenosis: A systematic review and meta-analysis of randomized controlled trials},
journal = {CardioVascular and Interventional Radiology},
year = {2025},
doi = {10.1007/s00270-025-04279-1}
}
EUVIMED